Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Aminocaproic acid
Drug ID BADD_D00106
Description An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
Indications and Usage For use in the treatment of excessive postoperative bleeding.
Marketing Status Prescription; Discontinued
ATC Code B02AA01
DrugBank ID DB00513
KEGG ID D00160
MeSH ID D015119
PubChem ID 564
TTD Drug ID D0FD0H
NDC Product Code 52584-346; 71151-026; 42799-054; 72572-015; 69766-054; 52817-815; 0517-9191; 71052-265; 17478-769; 0517-9120; 0404-9812; 69315-232; 0904-7165; 66689-330; 46438-0641; 59285-019; 60219-1637; 69315-503; 69680-115; 17478-768; 60687-505; 69315-231; 49411-052; 72205-049; 69680-116; 69539-161; 76055-0030; 69238-1596; 70966-0010; 49411-050; 69238-1637; 47621-310; 49411-051; 62559-225; 0409-4346; 51927-0046; 17478-447; 65571-0025
Synonyms Aminocaproic Acid | 6-Aminohexanoic Acid | 6 Aminohexanoic Acid | epsilon-Aminocaproic Acid | epsilon Aminocaproic Acid | 6-Aminocaproic Acid | 6 Aminocaproic Acid | Capralense | Capramol | Caproamin | Caprocid | Hexalense | CY-116 | CY 116 | CY116 | Epsamon | Epsikapron | Hemocaprol | Amicar | Caprolest
Chemical Information
Molecular Formula C6H13NO2
CAS Registry Number 60-32-2
SMILES C(CCC(=O)O)CCN
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Agranulocytosis01.02.03.001--Not Available
Anaphylactic reaction10.01.07.001; 24.06.03.006--
Anaphylactic shock10.01.07.002; 24.06.02.004--Not Available
Anaphylactoid reaction10.01.07.003; 24.06.03.007--Not Available
Anxiety19.06.02.0020.001089%
Blood creatine phosphokinase increased13.04.01.001--
Blood urea increased13.13.01.006--Not Available
Bradycardia02.03.02.002--Not Available
Cerebrovascular accident17.08.01.007; 24.03.05.001--
Coagulopathy01.01.02.001--Not Available
Confusional state17.02.03.005; 19.13.01.001--
Death08.04.01.001--
Delirium19.13.02.001--
Dermatitis23.03.04.002--Not Available
Diarrhoea07.02.01.001--
Discomfort08.01.08.003--Not Available
Dizziness02.01.02.004; 17.02.05.003; 24.06.02.0070.002178%
Drug hypersensitivity10.01.01.0010.001089%Not Available
Dyspnoea02.01.03.002; 22.02.01.004--
Ejaculation disorder21.03.01.002--
Epistaxis22.04.03.001; 24.07.01.0050.001634%
Erythema23.03.06.0010.001089%Not Available
Feeling abnormal08.01.09.014--Not Available
Fluid overload02.05.04.004; 14.05.06.0010.001089%Not Available
Flushing08.01.03.025; 23.06.05.003; 24.03.01.0020.001089%
Gastrointestinal pain07.01.05.005--
Hallucination19.10.02.002--
Headache17.14.01.001--
Hepatotoxicity09.01.07.009; 12.03.01.008--Not Available
The 1th Page    1 2 3    Next   Last    Total 3 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene